Current and historical daily PE Ratio for Medexus Pharmaceuticals Inc (
TSX:MDP
) from 2012 to Apr 28 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Medexus Pharmaceuticals stock (TSX:MDP) PE ratio as of Apr 28 2024 is 4.68.
More Details
Medexus Pharmaceuticals Inc (TSX:MDP) PE Ratio (TTM) Chart
Medexus Pharmaceuticals Inc (TSX:MDP) PE Ratio (TTM) Historical Data
View and export this data going back to 2012. Start your Free Trial
Total 1221
- 1
- 2
- 3
- 4
- 5
- 6
- 14
| Medexus Pharmaceuticals PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-04-29 | 4.7 | 2024-02-23 | 4.2 |
| 2024-04-26 | 4.7 | 2024-02-22 | 4.1 |
| 2024-04-25 | 4.5 | 2024-02-21 | 4.3 |
| 2024-04-24 | 4.2 | 2024-02-20 | 4.0 |
| 2024-04-23 | 4.0 | 2024-02-16 | 4.3 |
| 2024-04-22 | 4.0 | 2024-02-15 | 4.4 |
| 2024-04-19 | 4.0 | 2024-02-14 | 4.3 |
| 2024-04-18 | 3.8 | 2024-02-13 | 4.1 |
| 2024-04-17 | 3.7 | 2024-02-12 | 4.4 |
| 2024-04-16 | 3.8 | 2024-02-09 | 4.6 |
| 2024-04-15 | 3.8 | 2024-02-08 | 4.7 |
| 2024-04-12 | 3.9 | 2024-02-07 | 6.6 |
| 2024-04-11 | 3.8 | 2024-02-06 | 6.5 |
| 2024-04-10 | 3.8 | 2024-02-05 | 6.3 |
| 2024-04-09 | 3.8 | 2024-02-02 | 6.0 |
| 2024-04-08 | 3.9 | 2024-02-01 | 5.7 |
| 2024-04-05 | 4.0 | 2024-01-31 | 5.7 |
| 2024-04-04 | 4.0 | 2024-01-30 | 5.8 |
| 2024-04-03 | 4.1 | 2024-01-29 | 6.1 |
| 2024-04-02 | 3.8 | 2024-01-26 | 6.2 |
| 2024-04-01 | 3.9 | 2024-01-25 | 6.2 |
| 2024-03-28 | 3.9 | 2024-01-24 | 6.2 |
| 2024-03-27 | 4.2 | 2024-01-23 | 5.9 |
| 2024-03-26 | 4.2 | 2024-01-22 | 6.1 |
| 2024-03-25 | 3.7 | 2024-01-19 | 6.1 |
| 2024-03-22 | 3.8 | 2024-01-18 | 6.2 |
| 2024-03-21 | 3.8 | 2024-01-17 | 6.4 |
| 2024-03-20 | 3.8 | 2024-01-16 | 6.5 |
| 2024-03-19 | 3.7 | 2024-01-15 | 7.0 |
| 2024-03-18 | 3.8 | 2024-01-12 | 6.5 |
| 2024-03-15 | 3.8 | 2024-01-11 | 5.9 |
| 2024-03-14 | 3.8 | 2024-01-10 | 6.5 |
| 2024-03-13 | 3.9 | 2024-01-09 | 7.0 |
| 2024-03-12 | 4.0 | 2024-01-08 | 7.6 |
| 2024-03-11 | 4.1 | 2024-01-05 | 7.0 |
| 2024-03-08 | 4.2 | 2024-01-04 | 6.3 |
| 2024-03-07 | 4.2 | 2024-01-03 | 6.3 |
| 2024-03-06 | 4.2 | 2024-01-02 | 6.2 |
| 2024-03-05 | 4.2 | 2023-12-29 | 6.0 |
| 2024-03-04 | 4.2 | 2023-12-28 | 5.7 |
| 2024-03-01 | 4.4 | 2023-12-27 | 6.7 |
| 2024-02-29 | 4.3 | 2023-12-22 | 6.4 |
| 2024-02-28 | 4.4 | 2023-12-21 | 6.1 |
| 2024-02-27 | 4.4 | 2023-12-20 | 6.0 |
| 2024-02-26 | 4.3 | 2023-12-19 | 5.6 |
Medexus Pharmaceuticals Inc (TSX:MDP) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Medexus Pharmaceuticals Inc
NAICS : 325412
SIC : 3741
ISIN : CA70533E1088
Compare
Compare
Traded in other countries / regions
MDP.CanadaMEDXF.USAP731.Germany IPO Date
2012-03-05Description
Medexus Pharmaceuticals Inc is an innovative and rare disease pharmaceutical company with a strong North American commercial platform and a portfolio of proven best-in-class products. The company's focus is on the therapeutic areas of hematology, auto-immune diseases, and allergy.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers